Salvatore Mazzeo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Salvatore Mazzeo has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Valentina Bessi
Department of Neuroscience, Psychology, Drug Research and Child Health University of Florence Florence Italy
25 shared publications - Sandro Sorbi
IRCCS Fondazione Don Carlo Gnocchi ONLUS, 50143 Florence, Italy
18 shared publications Sonia Padiglioni
SOD Neurologia, Dipartimento Neuromuscolo-Scheletrico e degli Organi di Senso, AOU Careggi, Florence, Italy
18 shared publications- Benedetta Nacmias
Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy
15 shared publications - Giulia Giacomucci
Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy
14 shared publications Silvia Bagnoli
Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy
14 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (11) , 219
Combining Peripheral Inflammatory Biomarkers and aEEG Background Monitoring to Predict Neurological Outcome in Neonates Undergoing Cardiac Surgery for Congenital Heart Disease: A Real-World Pilot Experience
Background: Neonates with congenital heart disease (CHD) are at increased risk of neurological deficits. We investigated perioperative trajectories of neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-albumin ratio (MAR), their association with amplitude-integrated EEG (aEEG) background, and their contribution to short-term neurological outcome prediction. Methods: We retrospectively studied 64 neonates with CHD admitted for surgical evaluation. Combined conventional EEG/amplitude EEG (cEEG/aEEG) monitoring was performed pre-operatively (T0), within 24 h after surgery (T1), and 7–10 days post-operatively (T2). aEEG background was dichotomized as normal or abnormal. NLR and MAR were calculated from routine laboratory parameters. Associations with aEEG background and neurological outcome at intensive care unit discharge were assessed using non-parametric analyses and receiver operating characteristic curves. Results: Both NLR and MAR values showed significant perioperative longitudinal variation, characterized by a transient post-operative increase followed by normalization at one week. NLR demonstrated a consistent association with worsening aEEG background across all timepoints (T0: ρ = 0.566, pFDR < 0.001; ρ = 0.363, pFDR = 0.013; T2: ρ = 0.477, pFDR < 0.001), whereas MAR showed no significant association with neurophysiological abnormalities. Higher T2 NLR was associated with unfavorable short-term neurological outcome (ρ = 0.397, p_FDR = 0.016). T2 aEEG background and NLR showed comparable discriminative performance (AUC = 0.783 and 0.760, respectively). The combined NLR + aEEG model yielded a numerically higher AUC (0.844), although the improvement was not statistically significant. Conclusions: Our findings suggest an exploratory association between perioperative systemic inflammation and neurophysiological dysfunction in neonates with CHD. NLR may represent a potential adjunctive marker of perioperative cerebral dysfunction, although with susceptibility to systemic and perioperative complications. These preliminary findings warrant further investigation of inflammatory biomarkers alongside aEEG monitoring to better characterize their potential role in neurological risk stratification.
- 18 November 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (11) , 219
Open AccessCombining Peripheral Inflammatory Biomarkers and aEEG Background Monitoring to Predict Neurological Outcome in Neonates Undergoing Cardiac Surgery for Congenital Heart Disease: A Real-World Pilot Experience
Background: Neonates with congenital heart disease (CHD) are at increased risk of neurological deficits. We investigated perioperative trajectories of neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-albumin ratio (MAR), their association with amplitude-integrated EEG (aEEG) background, and their contribution to short-term neurological outcome prediction. Methods: We retrospectively studied 64 neonates with CHD admitted for surgical evaluation. Combined conventional EEG/amplitude EEG (cEEG/aEEG) monitoring was performed pre-operatively (T0), within 24 h after surgery (T1), and 7–10 days post-operatively (T2). aEEG background was dichotomized as normal or abnormal. NLR and MAR were calculated from routine laboratory parameters. Associations with aEEG background and neurological outcome at intensive care unit discharge were assessed using non-parametric analyses and receiver operating characteristic curves. Results: Both NLR and MAR values showed significant perioperative longitudinal variation, characterized by a transient post-operative increase followed by normalization at one week. NLR demonstrated a consistent association with worsening aEEG background across all timepoints (T0: ρ = 0.566, pFDR < 0.001; ρ = 0.363, pFDR = 0.013; T2: ρ = 0.477, pFDR < 0.001), whereas MAR showed no significant association with neurophysiological abnormalities. Higher T2 NLR was associated with unfavorable short-term neurological outcome (ρ = 0.397, p_FDR = 0.016). T2 aEEG background and NLR showed comparable discriminative performance (AUC = 0.783 and 0.760, respectively). The combined NLR + aEEG model yielded a numerically higher AUC (0.844), although the improvement was not statistically significant. Conclusions: Our findings suggest an exploratory association between perioperative systemic inflammation and neurophysiological dysfunction in neonates with CHD. NLR may represent a potential adjunctive marker of perioperative cerebral dysfunction, although with susceptibility to systemic and perioperative complications. These preliminary findings warrant further investigation of inflammatory biomarkers alongside aEEG monitoring to better characterize their potential role in neurological risk stratification.
- Open Access
- 15 June 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (6) , e71596
Expanding the role of insulin resistance to the earliest phases of cognitive decline: Preliminary evidence
- 15 June 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (6) , e71596
Open AccessExpanding the role of insulin resistance to the earliest phases of cognitive decline: Preliminary evidence
- Open Access
The Role of Background Activity Monitoring by Amplitude-Integrated EEG to Predict Short-Term Neurological Outcome in Neonates with Congenital Heart Disease: Insights from a Real-Life Retrospective Cohort
Neonates undergoing surgery for congenital heart disease (CHD) are at high risk for brain function impairment. Reliable early predictors of postoperative neurological complications are lacking. We examined a retrospective cohort of 55 surgically treated CHD neonates systematically monitored by concomitant conventional electroencephalography (cEEG) and amplitude-integrated EEG (aEEG). Neonates underwent cEEG/aEEG at three time points: T0 (preoperative, duration: 90–120 min); T1 (24–48 h after cardiac surgery, duration: ≥11 h); and T2 (7–10 days post-surgery, duration: 90–120 min). For each patient, aEEG background activity was evaluated and scored, and clinical and surgical data were retrieved to establish short-term post-surgical outcomes. Patients with normal T0 monitoring had significantly higher aEEG bandwidths in T1. A lower Aristotle basic score was associated with an improvement in aEEG at T1. Inversely, a narrower aEEG bandwidth in T1 was associated with post-surgical neurological deterioration. The aEEG bandwidth accurately predicted short-term neurological outcome; in particular, a minimal aEEG amplitude above 17.5 µV excluded poor neurological outcome with a negative predictive value of 81.48%. Our results demonstrated that aEEG bandwidth and trend dynamics may be associated with surgical complexity and neurological outcomes. aEEG background trend monitoring may provide relevant prognostic information on neurological outcomes in surgically treated CHD neonates.
Open AccessThe Role of Background Activity Monitoring by Amplitude-Integrated EEG to Predict Short-Term Neurological Outcome in Neonates with Congenital Heart Disease: Insights from a Real-Life Retrospective Cohort
Neonates undergoing surgery for congenital heart disease (CHD) are at high risk for brain function impairment. Reliable early predictors of postoperative neurological complications are lacking. We examined a retrospective cohort of 55 surgically treated CHD neonates systematically monitored by concomitant conventional electroencephalography (cEEG) and amplitude-integrated EEG (aEEG). Neonates underwent cEEG/aEEG at three time points: T0 (preoperative, duration: 90–120 min); T1 (24–48 h after cardiac surgery, duration: ≥11 h); and T2 (7–10 days post-surgery, duration: 90–120 min). For each patient, aEEG background activity was evaluated and scored, and clinical and surgical data were retrieved to establish short-term post-surgical outcomes. Patients with normal T0 monitoring had significantly higher aEEG bandwidths in T1. A lower Aristotle basic score was associated with an improvement in aEEG at T1. Inversely, a narrower aEEG bandwidth in T1 was associated with post-surgical neurological deterioration. The aEEG bandwidth accurately predicted short-term neurological outcome; in particular, a minimal aEEG amplitude above 17.5 µV excluded poor neurological outcome with a negative predictive value of 81.48%. Our results demonstrated that aEEG bandwidth and trend dynamics may be associated with surgical complexity and neurological outcomes. aEEG background trend monitoring may provide relevant prognostic information on neurological outcomes in surgically treated CHD neonates.
- Open Access
- 27 March 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (4) , e70552
Staging Language‐Led Neurodegenerative Diseases in a Language‐Based World: The Challenge of the PPA ‐Squared Scale
- 27 March 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (4) , e70552
Open AccessStaging Language‐Led Neurodegenerative Diseases in a Language‐Based World: The Challenge of the PPA ‐Squared Scale
- 28 January 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 110 (2) , 728-745
Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic
Background: Subjective cognitive decline (SCD) represents the first early symptomatic stage of Alzheimer's disease (AD). Objective: We aimed to investigate the relationships between features in SCD and to assess the importance of these features in the future development of dementia to inform a targeted management protocol. Methods: 440 SCD patients underwent neurological and neuropsychological assessments, MRI scans, APOE genotyping, and AD biomarker evaluations. Patients were followed for a median of 10 years. Relationships among features were first assessed univariately, focusing on differences across stratified subgroups. To capture multivariate associations, we applied network analysis using a Markov Random Field. Finally, baseline features were related to dementia progression using an XGboost machine learning model. Results: Women comprising 68.9% of the cohort, were generally younger at onset, had lower APOE ε4 prevalence, and differed in neuropsychological performance compared to men. Older patients (age >60) exhibited a higher prevalence of APOE ε4 and cerebral small vessel disease. Patients with depressive symptoms demonstrated lower cognitive performance across multiple domains. Network analysis indicated complex interconnections among gender, cognitive reserve, SCD severity, and depressive symptoms. The XGboost model achieved 74% accuracy in predicting progression to dementia, identifying age at onset, mini-mental state examination scores, and APOE genotype as the most predictive factors. Conclusions: This study highlights the role of age, gender, APOE genotype, and depressive symptoms in the presentation and progression of cognitive decline. By identifying key predictive features, we propose a personalized management protocol aimed at optimizing care for individuals with SCD. Trial registration number: NCT05569083, registration date: 2019-05-30
- 28 January 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 110 (2) , 728-745
Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic
Background: Subjective cognitive decline (SCD) represents the first early symptomatic stage of Alzheimer's disease (AD). Objective: We aimed to investigate the relationships between features in SCD and to assess the importance of these features in the future development of dementia to inform a targeted management protocol. Methods: 440 SCD patients underwent neurological and neuropsychological assessments, MRI scans, APOE genotyping, and AD biomarker evaluations. Patients were followed for a median of 10 years. Relationships among features were first assessed univariately, focusing on differences across stratified subgroups. To capture multivariate associations, we applied network analysis using a Markov Random Field. Finally, baseline features were related to dementia progression using an XGboost machine learning model. Results: Women comprising 68.9% of the cohort, were generally younger at onset, had lower APOE ε4 prevalence, and differed in neuropsychological performance compared to men. Older patients (age >60) exhibited a higher prevalence of APOE ε4 and cerebral small vessel disease. Patients with depressive symptoms demonstrated lower cognitive performance across multiple domains. Network analysis indicated complex interconnections among gender, cognitive reserve, SCD severity, and depressive symptoms. The XGboost model achieved 74% accuracy in predicting progression to dementia, identifying age at onset, mini-mental state examination scores, and APOE genotype as the most predictive factors. Conclusions: This study highlights the role of age, gender, APOE genotype, and depressive symptoms in the presentation and progression of cognitive decline. By identifying key predictive features, we propose a personalized management protocol aimed at optimizing care for individuals with SCD. Trial registration number: NCT05569083, registration date: 2019-05-30
- Open Access
TMS–EEG Reveals Distinct Cortical Signatures in Non-Fluent PPA
Primary Progressive Aphasias (PPA) are a group of neurodegenerative disorders characterized by the gradual decline of language abilities. They are typically divided into three major clinical variants: the non-fluent (nfvPPA), the semantic (svPPA) and the logopenic (lvPPA) variant. Even with an extensive clinical examination, a correct differential diagnosis among variants can be difficult due to the overlapping of dysfunctional language features. In this context, the combination of Transcranial Magnetic Stimulation and Electroencephalography (i.e., TMS–EEG) could extend our understanding of nfvPPA pathophysiology, given the possibility to non-invasively and directly measure cortical reactivity of brain speech networks to external perturbations. Twenty PPA patients (7 nfvPPA, 13 lvPPA) and 8 elderly controls underwent a TMS–EEG session targeting the left dorsal premotor cortex (Brodmann area 6). A subset of 9 patients (8 lvPPA, 1 nfvPPA) were additionally stimulated in the right homologous region. We automatically detected the EEG channel under the stimulator with the highest peak-to-peak amplitude of the early TMS-evoked response and computed the following measures: (i) natural frequency; (ii) normalized evoked spectral power in the alpha, low-beta, high-beta and gamma range. Non-fluent PPA patients showed a slower and simplified TMS-evoked response as compared to healthy elderly subjects, namely a reduction in high-beta power and natural frequency coupled with higher low frequencies (i.e., alpha) intrusion. No significant differences were detected between lvPPA and controls or nfvPPA and lvPPA. The speech rate was positively correlated with TMS–EEG measures (the high-beta power and the natural frequency). Furthermore, compared to the left side, the stimulation of the right hemisphere elicited TMS-evoked responses with higher natural frequency and high-beta power in both lvPPA and nfvPPA patients. This study first shows that TMS–EEG may provide useful neurophysiological biomarkers for characterizing the nfvPPA variant and monitor disease progression across variants. These findings might be employed in the future to stratify patients and eventually inform the application of variant-specific stimulation protocols tailored to individual neurophysiological profiles.
Open AccessTMS–EEG Reveals Distinct Cortical Signatures in Non-Fluent PPA
Primary Progressive Aphasias (PPA) are a group of neurodegenerative disorders characterized by the gradual decline of language abilities. They are typically divided into three major clinical variants: the non-fluent (nfvPPA), the semantic (svPPA) and the logopenic (lvPPA) variant. Even with an extensive clinical examination, a correct differential diagnosis among variants can be difficult due to the overlapping of dysfunctional language features. In this context, the combination of Transcranial Magnetic Stimulation and Electroencephalography (i.e., TMS–EEG) could extend our understanding of nfvPPA pathophysiology, given the possibility to non-invasively and directly measure cortical reactivity of brain speech networks to external perturbations. Twenty PPA patients (7 nfvPPA, 13 lvPPA) and 8 elderly controls underwent a TMS–EEG session targeting the left dorsal premotor cortex (Brodmann area 6). A subset of 9 patients (8 lvPPA, 1 nfvPPA) were additionally stimulated in the right homologous region. We automatically detected the EEG channel under the stimulator with the highest peak-to-peak amplitude of the early TMS-evoked response and computed the following measures: (i) natural frequency; (ii) normalized evoked spectral power in the alpha, low-beta, high-beta and gamma range. Non-fluent PPA patients showed a slower and simplified TMS-evoked response as compared to healthy elderly subjects, namely a reduction in high-beta power and natural frequency coupled with higher low frequencies (i.e., alpha) intrusion. No significant differences were detected between lvPPA and controls or nfvPPA and lvPPA. The speech rate was positively correlated with TMS–EEG measures (the high-beta power and the natural frequency). Furthermore, compared to the left side, the stimulation of the right hemisphere elicited TMS-evoked responses with higher natural frequency and high-beta power in both lvPPA and nfvPPA patients. This study first shows that TMS–EEG may provide useful neurophysiological biomarkers for characterizing the nfvPPA variant and monitor disease progression across variants. These findings might be employed in the future to stratify patients and eventually inform the application of variant-specific stimulation protocols tailored to individual neurophysiological profiles.
- 1 October 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (10) , 1-15
Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer’s disease biomarkers, and clinical trajectories
Objectives Subjective Cognitive Decline (SCD) is a heterogeneous condition recognized as the earliest manifestation of Alzheimer’s disease (AD). We hypothesized that the heterogeneity of SCD may be synthesized in distinct subtypes. Methods We analyzed data from the AD Neuroimaging Initiative (ADNI) database. For all participants, demographic variables, cognitive measures, APOE genotype, CSF biomarkers, brain MRI, and FDG-PET data were available. Participants underwent follow-up visits every 6 or 12 months. Results 542 cognitively normal (CN), 346 SCD, and 423 early mild cognitive impairment (E-MCI) individuals were included. A data-driven approach based on cognitive measures identified three SCD clusters (k1, k2, k3) that performed differently in verbal memory (k2 outperformed all the groups and k3 showed the poorest performance, p < 0.001) and in executive function (k1 had the lowest scores, p = 0.006). Regarding CSF biomarkers, k2 exhibited lower p-tau (20.6 ± 9.2 vs. 24.2 ± 13.6, p = 0.03) and k3 had higher Aβ42 levels (1131.3 ± 379.8 vs. 942.87 ± 355.3, p = 0.01) compared to the E-MCI group, while there were no differences between k1 and E-MCI. Regarding brain FDG-PET, k1 demonstrated reduced uptake compared to CN, k2, and k3 (p < 0.001). During follow-up, k1 exhibited a higher rate of progression to MCI or dementia compared to k2 and k3 (Log-rank χ2 = 18.18, p = 0.0002) and a steeper decline in general cognition and long-term verbal memory compared to k2. Interpretation We proposed a three-subgroup system classification for SCD, reflecting different cognitive profiles and longitudinal trajectories. Classifying individuals with SCD may enhance diagnostic pathways and inform personalized interventions.
- 1 October 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (10) , 1-15
Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer’s disease biomarkers, and clinical trajectories
Objectives Subjective Cognitive Decline (SCD) is a heterogeneous condition recognized as the earliest manifestation of Alzheimer’s disease (AD). We hypothesized that the heterogeneity of SCD may be synthesized in distinct subtypes. Methods We analyzed data from the AD Neuroimaging Initiative (ADNI) database. For all participants, demographic variables, cognitive measures, APOE genotype, CSF biomarkers, brain MRI, and FDG-PET data were available. Participants underwent follow-up visits every 6 or 12 months. Results 542 cognitively normal (CN), 346 SCD, and 423 early mild cognitive impairment (E-MCI) individuals were included. A data-driven approach based on cognitive measures identified three SCD clusters (k1, k2, k3) that performed differently in verbal memory (k2 outperformed all the groups and k3 showed the poorest performance, p < 0.001) and in executive function (k1 had the lowest scores, p = 0.006). Regarding CSF biomarkers, k2 exhibited lower p-tau (20.6 ± 9.2 vs. 24.2 ± 13.6, p = 0.03) and k3 had higher Aβ42 levels (1131.3 ± 379.8 vs. 942.87 ± 355.3, p = 0.01) compared to the E-MCI group, while there were no differences between k1 and E-MCI. Regarding brain FDG-PET, k1 demonstrated reduced uptake compared to CN, k2, and k3 (p < 0.001). During follow-up, k1 exhibited a higher rate of progression to MCI or dementia compared to k2 and k3 (Log-rank χ2 = 18.18, p = 0.0002) and a steeper decline in general cognition and long-term verbal memory compared to k2. Interpretation We proposed a three-subgroup system classification for SCD, reflecting different cognitive profiles and longitudinal trajectories. Classifying individuals with SCD may enhance diagnostic pathways and inform personalized interventions.
- 27 September 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (12)
Expanding the framework on multimodal biomarkers in isolated REM sleep behavior disorder: Response to Carpi et al.
- 27 September 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (12)
Expanding the framework on multimodal biomarkers in isolated REM sleep behavior disorder: Response to Carpi et al.
- 22 July 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (2) , e213922
Exploring the Sociobiological Mechanisms of Diseases
- 22 July 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (2) , e213922
Exploring the Sociobiological Mechanisms of Diseases